Metabolic Solutions Development is a cutting-edge biotechnology company based in Kalamazoo, MI, dedicated to the prevention and treatment of metabolic diseases. With a focus on metabolic syndrome and type 2 diabetes, their innovative science and targeted approach offer new hope for patients worldwide.
Through the development of insulin sensitizers and advancements in neurodegeneration research, Metabolic Solutions Development is at the forefront of finding solutions to combat these prevalent health conditions. With a robust pipeline that includes promising compounds like MSDC-0160 and CIRIUS MSDC-0602, the company is committed to making a significant impact on the lives of individuals affected by metabolic diseases.
Generated from the website